Status:
UNKNOWN
Subclinical Cardiac Involvement in Patients With Inflamatory Bowel Disease
Lead Sponsor:
Hossam Eldin Mohammed Essam Abdelhafez
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
Aim of the study is to determine the prevelance of subclinical cardiac involvement in patients with inflamatory bowel disease.
Detailed Description
Cardiovascular manifestations in patients with IBD mostly occur as immune-related consequences and include the following: pericarditis, myocarditis, venous and arterial thromboembolism, left ventricle...
Eligibility Criteria
Inclusion
- Inflamatory bowel disease patients without previous history of cardiac disease.
Exclusion
- Patients known to have previous cardiac disease.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04330105
Start Date
May 1 2020
End Date
July 30 2022
Last Update
April 3 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.